← Back to directory

John Atack

Researcher Next ID · RN-031774

Researcher · Biochemistry, Genetics and Molecular Biology

Discovery Institute

Seattle, United Kingdom

Accepting doctoral researchersFunding unknown
Works count
1,424
Citation count
14,605
H-index
64
i10-index
180

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Neuroscience
Neuroscience and Neuropharmacology Research
Memory and Neural Mechanisms
Receptor Mechanisms and Signaling
Pharmacological Receptor Mechanisms and Effects
Cholinesterase and Neurodegenerative Diseases

Publications

  • Summary of Product Characteristics

    Journal · 2010 · https://doi.org/10.1007/978-3-540-68706-1_698

  • Did Railroads Induce or Follow Economic Growth?: Urbanization and Population Growth in the American Midwest, 1850-1860

    Social Science History · 2010 · 10.1215/01455532-2009-024

  • The complexity of the GABAA receptor shapes unique pharmacological profiles

    Drug Discovery Today · 2009 · 10.1016/j.drudis.2009.06.009

  • R3(BΔ23–27)R/I5 Chimeric Peptide, a Selective Antagonist for GPCR135 and GPCR142 over Relaxin Receptor LGR7

    Journal of Biological Chemistry · 2007 · 10.1074/jbc.m701416200

  • Selective Blockade of 5-Hydroxytryptamine (5-HT)7 Receptors Enhances 5-HT Transmission, Antidepressant-Like Behavior, and Rapid Eye Movement Sleep Suppression Induced by Citalopram in Rodents

    Journal of Pharmacology and Experimental Therapeutics · 2007 · 10.1124/jpet.107.119404

  • L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors

    Neuropharmacology · 2006 · 10.1016/j.neuropharm.2006.04.018

  • An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition

    Journal of Pharmacology and Experimental Therapeutics · 2006 · 10.1124/jpet.105.092320

  • Different GABA A receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates

    Proceedings of the National Academy of Sciences · 2005 · 10.1073/pnas.0405621102

  • Evidence for a Significant Role of α3-Containing GABAAReceptors in Mediating the Anxiolytic Effects of Benzodiazepines

    Journal of Neuroscience · 2005 · 10.1523/jneurosci.1166-05.2005

  • TPA023 [7-(1,1-Dimethylethyl)-6-(2-ethyl-2 H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an Agonist Selective for α2- and α3-Containing GABAA Receptors, Is a Nonsedating Anxiolytic in Rodents and Primates

    Journal of Pharmacology and Experimental Therapeutics · 2005 · 10.1124/jpet.105.089920

  • The benzodiazepine binding site of GABAAreceptors as a target for the development of novel anxiolytics

    Expert Opinion on Investigational Drugs · 2005 · 10.1517/13543784.14.5.601

  • Sedation and Anesthesia Mediated by Distinct GABA A Receptor Isoforms

    Journal of Neuroscience · 2003 · 10.1523/jneurosci.23-24-08608.2003

  • Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms.

    PubMed · 2003 · 10.1523/jneurosci.23-24-08608.2003

  • Identification of a Novel, Selective GABAAα5 Receptor Inverse Agonist Which Enhances Cognition

    Journal of Medicinal Chemistry · 2003 · 10.1021/jm020582q

  • Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA A Receptor

    Journal of Neuroscience · 2002 · https://doi.org/10.1523/jneurosci.22-13-05572.2002

  • Loss of the Major GABA A Receptor Subtype in the Brain Is Not Lethal in Mice

    Journal of Neuroscience · 2001 · 10.1523/jneurosci.21-10-03409.2001

  • Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidAReceptors Determined Using36Cl Ion Flux

    Molecular Pharmacology · 2001 · 10.1124/mol.59.5.1108

  • Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype

    Nature Neuroscience · 2000 · https://doi.org/10.1038/75761

  • Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain

    Brain Research · 1999 · 10.1016/s0006-8993(99)01152-x

  • Preferential Coassembly of α4 and δ Subunits of the γ-Aminobutyric AcidAReceptor in Rat Thalamus

    Molecular Pharmacology · 1999 · 10.1124/mol.56.1.110

  • Structure of inositol monophosphatase, the putative target of lithium therapy.

    Proceedings of the National Academy of Sciences · 1992 · 10.1073/pnas.89.21.10031

  • Cerebrospinal fluid production is reduced in healthy aging

    Neurology · 1990 · https://doi.org/10.1212/wnl.40.3_part_1.500

  • Reductions in [ 3 H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease

    Neurology · 1988 · 10.1212/wnl.38.5.720

  • Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System

    Journal of Neurochemistry · 1986 · 10.1111/j.1471-4159.1986.tb02858.x

  • ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE

    The Lancet · 1986 · https://doi.org/10.1016/s0140-6736(86)92319-6

  • Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

    Journal of Neurology Neurosurgery & Psychiatry · 1985 · https://doi.org/10.1136/jnnp.48.5.413

  • Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form

    Neuroscience Letters · 1983 · 10.1016/0304-3940(83)90302-6

Current projects

    No projects listed.